4.7 Article

DUSP4-mediated accelerated T-cell senescence in idiopathic CD4 lymphopenia

期刊

BLOOD
卷 125, 期 16, 页码 2507-2518

出版社

AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2014-08-598565

关键词

-

资金

  1. Agence Nationale de la Recherche (ANR) [2010-JCJC-110401]
  2. Programme Hospitalier de Recherche Clinique, French Ministry of Health [2009-01-55]
  3. ANR [ANR-10-LABX-33, ANR-11-IDEX-0003-01]
  4. French Ministry
  5. Fondation pour la Recherche Medicale [FDT20130928127]
  6. Laboratoire d'Excellence en Recherche sur le Medicament et l'Innovation Therapeutique
  7. Assistance Publique-Hopitaux de Paris

向作者/读者索取更多资源

Idiopathic CD4 lymphopenia (ICL) is a rare heterogeneous immunological syndrome of unclear etiology. ICL predisposes patients to severe opportunistic infections and frequently leads to poor vaccination effectiveness. Chronic immune activation, expansion of memory T cells, and impaired T-cell receptor (TCR) signaling have been reported in ICL, but the mechanistic and causative links remain unclear. We show that late-differentiated T cells in 20 patients with ICL displayed defective TCR responses and aging markers similar to those found in T cells from elderly subjects. Intrinsic T-cell defects were caused by increased expression of dual-specific phosphatase 4 (DUSP4). Normalization of DUSP4 expression using a specific siRNA improved CD4 1 T-cell activity in ICL, as this restored TCR-induced extracellular signal-regulated kinase activation and increased the expression of the costimulatory molecules CD27 and CD40L. Conversely, repeated TCR stimulation led to defective signaling and DUSP4 overexpression in control CD4 1 T cells. This was associated with gradual acquisition of a memory phenotype and was curtailed by DUSP4 silencing. These findings identify a premature T-cell senescence in ICL that might be caused by chronic T-cell activation and a consequential DUSP4-dependent dampening of TCR signaling.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据